Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2Phase 3 Interventional Results available

A Dose Finding, Efficacy and Safety Study of Ensovibep (MP0420) in Ambulatory Adult Patients With Symptomatic COVID-19

ClinicalTrials.gov ID: NCT04828161

Public ClinicalTrials.gov record NCT04828161. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 3, 2026, 6:58 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Ensovibep (MP0420) in Ambulatory Adult Patients With Symptomatic COVID-19 - The "EMPATHY" Trial

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to establish the antiviral efficacy of ensovibep against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in humans, identify the optimal dose, and demonstrate its clinical value for treating COVID-19 in adult ambulatory patients.

Study identification

NCT ID
NCT04828161
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2, Phase 3
Lead sponsor
Novartis Pharmaceuticals
Industry
Enrollment
407 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 9, 2021
Primary completion
Nov 17, 2021
Completion
Jan 26, 2022
Last update posted
Jan 26, 2026

2021 – 2022

United States locations

U.S. sites
27
U.S. states
11
U.S. cities
24
Facility City State ZIP Site status
Jasper Summit Research, LLC Jasper Alabama 35501
Benchmark Southern California Colton California 92324
Ascada Research Fullerton California 92835
Pacific Neuropsychiatric Specialists Mission Viejo California 92691
Providence Family Medical Center Redondo Beach California 90277
Future Innovative Treatments Colorado Springs Colorado 80907
Boward Infectious Disease and Primary Care Margate Florida 33063
Suncoast Research Group, LLC Miami Florida 33135
Life Spring Research Foundation Miami Florida 33155
Bio-Medical Research, LLC Miami Florida 33184
Panax Clinical Research, LLC Miami Lakes Florida 33014
AdventHealth Tampa Tampa Florida 33613
Palm Beach Research Center West Palm Beach Florida 33409
Gwinnett Research Institute Buford Georgia 30519
IACT Health Columbus Georgia 31904
Great Lakes Clinical Trials Chicago Illinois 60640
Centennial Medical Group - Research Department Elkridge Maryland 21075
Jefferson City Medical Group Jefferson City Missouri 65109
Monroe Biomedical Research Monroe North Carolina 28112
Wilmington Health Wilmington North Carolina 28412
VitaLink Research Greenville South Carolina 29615
Clinical Research of Rock Hill Rock Hill South Carolina 29732
Fairway Medical Clinic Houston Texas 77087
1960 Family Practice, PA Houston Texas 77090
Zion Urgent Care Clinic Katy Texas 77494
Family Practice Center McAllen Texas 78501
Epic Medical Research Red Oak Texas 75154

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 21 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04828161, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 26, 2026 · Synced Sep 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04828161 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →